117 related articles for article (PubMed ID: 30165631)
21. Adjuvant radiotherapy in carcinomas of the uterine cervix: the prognostic value of hemoglobin levels.
Münstedt K; Johnson P; Bohlmann MK; Zygmunt M; von Georgi R; Vahrson H
Int J Gynecol Cancer; 2005; 15(2):285-91. PubMed ID: 15823113
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Significance of Pretreatment Thrombocytosis in Cervical Cancer Patients Treated With Definitive Radiotherapy.
Kawano M; Mabuchi S; Matsumoto Y; Sasano T; Takahashi R; Kuroda H; Kozasa K; Isohashi F; Ogawa K; Kimura T
Int J Gynecol Cancer; 2015 Nov; 25(9):1656-62. PubMed ID: 26332391
[TBL] [Abstract][Full Text] [Related]
23. Treatment outcomes of patients with adenocarcinoma of the uterine cervix after definitive radiotherapy and the prognostic impact of tumor-infiltrating CD8+ lymphocytes in pre-treatment biopsy specimens: a multi-institutional retrospective study.
Miyasaka Y; Yoshimoto Y; Murata K; Noda SE; Ando K; Ebara T; Okonogi N; Kaminuma T; Yamada S; Ikota H; Yokoo H; Ohno T; Nakano T
J Radiat Res; 2020 Mar; 61(2):275-284. PubMed ID: 32052042
[TBL] [Abstract][Full Text] [Related]
24. Long-term results and prognostic factors in patients with stage III-IVA squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy from a single institution study.
Kudaka W; Nagai Y; Toita T; Inamine M; Asato K; Nakamoto T; Wakayama A; Ooyama T; Tokura A; Murayama S; Aoki Y
Int J Clin Oncol; 2013 Oct; 18(5):916-21. PubMed ID: 22898910
[TBL] [Abstract][Full Text] [Related]
25. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
[TBL] [Abstract][Full Text] [Related]
26. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.
Eleje GU; Eke AC; Igberase GO; Igwegbe AO; Eleje LI
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011000. PubMed ID: 25932968
[TBL] [Abstract][Full Text] [Related]
27. The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience.
Thomas G
Semin Oncol; 2001 Apr; 28(2 Suppl 8):60-5. PubMed ID: 11395855
[TBL] [Abstract][Full Text] [Related]
28. [Hydronephrosis as a prognostic factor for patients of figo IIIB cervical cancer].
Krynicki R; Bidziński M; Wierzba W; Panek G; Jońska J; Lindner B
Ginekol Pol; 2003 Jan; 74(1):32-9. PubMed ID: 12715435
[TBL] [Abstract][Full Text] [Related]
29. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
Höckel M; Hentschel B; Horn LC
Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
[TBL] [Abstract][Full Text] [Related]
30. Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy.
Wen YF; Cheng TT; Chen XL; Huang WJ; Peng HH; Zhou TC; Lin XD; Zeng LS
PLoS One; 2018; 13(10):e0204334. PubMed ID: 30303986
[TBL] [Abstract][Full Text] [Related]
31. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
Yeh SA; Wan Leung S; Wang CJ; Chen HC
Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of clinical efficacy of intensity-modulated radiation therapy and the prognosis factors in advanced cervical cancer].
Gao K; Ding L; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):30-5. PubMed ID: 24694915
[TBL] [Abstract][Full Text] [Related]
33. Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients.
Cho Y; Kim KH; Yoon HI; Kim GE; Kim YB
Ann Oncol; 2016 Nov; 27(11):2067-2074. PubMed ID: 27502717
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
35. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
36. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
37. Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01.
Lee JH; Lee SW; Kim JR; Kim YS; Yoon MS; Jeong S; Kim JH; Lee JY; Eom KY; Jeong BK; Lee SH
Gynecol Oncol; 2017 Dec; 147(3):577-584. PubMed ID: 29110878
[TBL] [Abstract][Full Text] [Related]
38. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic blood transfusion given before radiotherapy is associated with the poor clinical outcome in patients with cervical cancer.
Lim MC; Kim JY; Kim TH; Park S; Kong SY; Yoon JH; Kang S; Seo SS; Park SY
Yonsei Med J; 2008 Dec; 49(6):993-1003. PubMed ID: 19108024
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma.
Cho O; Chun M; Oh YT; Noh OK; Chang SJ; Ryu HS; Lee EJ
Tumour Biol; 2017 Oct; 39(10):1010428317733144. PubMed ID: 29022484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
